Urogen Pharma Ltd. · NASDAQ:URGN

Schoenberg Mark sold 10,000 Urogen Pharma Ltd. shares (Form 4)

Traded May 8, 2026 · Filed May 11, 2026

On May 8, 2026, Schoenberg Mark (Chief Medical Officer) sold 10,000 Urogen Pharma Ltd. shares at US$30.00 for US$300K under a trading plan, leaving 134,985 shares. Filed May 11, 2026 (Form 4).

Sold
10,000 shares
Price
US$30.00
Value
US$300K
Holding after
134,985 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 8, 2026Ordinary SharesSale10,000US$30.00134,985Direct

Source

View original at SEC

Related